Back to top

The Zacks Analyst Blog Highlights: Merck, Barclays, Activision Blizzard, Blackstone and Tyson Foods

Read MoreHide Full Article

For Immediate Release

Chicago, IL – May 11, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Merck (NYSE: (MRK - Free Report) Free Report ), Barclays (NYSE: (BCS - Free Report) Free Report ), Activision Blizzard (NASDAQ: (ATVI - Free Report) Free Report ), Blackstone (NYSE: (BX - Free Report) Free Report ) and Tyson Foods (NYSE: (TSN - Free Report) Free Report ).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free .

Here are highlights from Wednesday’s Analyst Blog:

Top Research Reports for Activision, Merck and Barclays

Today's Research Daily features new research reports on 16 major stocks, including Merck (NYSE: (MRK - Free Report) Free Report ), Barclays (NYSE:(BCS - Free Report) Free Report ) and Activision Blizzard (NASDAQ: (ATVI - Free Report) Free Report ).

Merck shares have performed largely in-line with the Zacks Large Cap Pharma industry in the year-to-date period (+8.3% for MRK vs. +7.6% for the industry), but the stock has handily outperformed the peer group over the past one year (+17.4% vs. +2.7%). This favorable momentum should continue following the company's better than expected Q1 results when it beat top- and bottom-line estimates and guided higher. The Zacks analyst likes Merck’s new products, especially Keytruda, which should continue to contribute meaningfully to the top line while management's cost-cutting initiatives should help the bottom line. The company has also made significant progress with its pipeline and is working on bringing new products to the market. However, generic competition and pricing pressure will likely remain headwinds as are rising competition in the immuno-oncology market. (You can read the full research report on Merck here >>> )

Barclays have underperformed the Zacks Foreign Banks industry this year, with BCS shares down -1.2% in the year-to-date period vs. +9.3% gain for the industry. Questions about the British bank's capital position, regulatory questions and the strong Pound have all been contributors to this underperformance. The bank's recent quarterly results were fairly strong, reflecting impressive underwriting performance and substantial drop in losses in Non-Core division. The company's efforts to restructure and simplify its operations should help outlook in the long run, but the aforementioned headwinds coupled with Brexit-related uncertainties will likely remain issues for some time. (You can read the full research report on Barclays here >>> )

Activision Blizzard shares have been strong performers this year, with the stock up +55.3% in the year-to-date period vs. the Zacks gaming industry's +29% gain in that same time period. The strong earnings reports for this quarter as well as the preceding one have added to the stock's momentum. The Zacks analyst likes Activision’s enviable product portfolio and increasing digital revenues, both of which should continue to drive growth. Moreover, the company stands to benefit further from the acquisition of King Digital. The company’s attempts to become a broad-based media company are also prudent. Apart from launching a movie studio and consumer products division, the company is strengthening its presence in the lucrative e-sports market. However, the hit driven and competitive nature of the video game industry begets caution. (You can read the full research report on Activision here >>> )

Other noteworthy reports we are featuring today include Blackstone (NYSE: (BX - Free Report) Free Report ) and Tyson Foods (NYSE: (TSN - Free Report) Free Report ).

Sell These Stocks. Now.

Just released, today's 220 Zacks Rank #5 Strong Sells demand urgent attention. If any are lurking in your portfolio or Watch List, they should be removed immediately. These sinister companies because many appear to be sound investments. However, from 1988 through 2016, stocks from our Strong Sell list have actually performed 6X worse than the S&P 500.

See today's Zacks "Strong Sells" absolutely free >>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free .

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Get the full Report on MRK - FREE

Get the full Report on BCS - FREE

Get the full Report on ATVI - FREE

Get the full Report on BX - FREE

Get the full Report on TSN - FREE

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Published in